Provided by Tiger Trade Technology Pte. Ltd.

Insulet

227.10
-1.5300-0.67%
Post-market: 227.760.6600+0.29%17:56 EDT
Volume:1.06M
Turnover:241.43M
Market Cap:15.98B
PE:65.28
High:230.25
Open:227.68
Low:224.32
Close:228.63
52wk High:354.88
52wk Low:216.49
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.92
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.48
EPS(LYR):3.48
ROE:18.12%
ROA:9.43%
PB:10.54
PE(LYR):65.28

Loading ...

Canaccord Genuity Adjusts Price Target on Insulet to $450 From $432, Maintains Buy Rating

MT Newswires Live
·
Dec 17, 2025

Insulet Corporation Director Wayne A.I. Frederick Reports Disposal of Common Shares

Reuters
·
Dec 17, 2025

Insulet Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Dec 16, 2025

Evercore ISI Initiates Coverage on Insulet With Outperform Rating, $370 Price Target

MT Newswires Live
·
Dec 16, 2025

Insulet Corporation to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 16, 2025

BUZZ-Insulet gets 'outperform' rating as Evercore starts coverage

Reuters
·
Dec 16, 2025

Insulet Corp : Evercore Isi Initiates Coverage With Outperform Rating; Target Price $370

THOMSON REUTERS
·
Dec 16, 2025

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Dec 16, 2025

Insulet Expands Omnipod Recycling Program Nationwide

Reuters
·
Dec 15, 2025

Director Timothy C. Stonesifer Acquires Common Shares of Insulet Corporation

Reuters
·
Dec 09, 2025

Insulet Names Cristal Downing Chief Corporate Affairs Officer

Reuters
·
Dec 08, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 05, 2025

Insulet Wins FDA Clearance for Enhanced Omnipod 5 Algorithm

Reuters
·
Dec 04, 2025

Insulet Corp - Omnipod 5 Algorithm Updates to Launch in U.S. in 2026

THOMSON REUTERS
·
Dec 04, 2025

Insulet Announces FDA 510(K) Clearance of Omnipod® 5 Algorithm Enhancements That Redefine Insulin Delivery and Simplify the Pod Experience

THOMSON REUTERS
·
Dec 04, 2025

Insulet (PODD): Assessing Valuation After Recent Share Price Cooldown

Simply Wall St.
·
Dec 04, 2025

Insulet Corp. Stock Sheds 5.0%, Underperforms Peers

Dow Jones
·
Dec 02, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Nov 25, 2025

Press Release: Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook

Dow Jones
·
Nov 25, 2025

Insulet Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Nov 24, 2025